Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1378 publications
Global Breast Cancer Vaccine Clinical Trial Insight US$ 1,200.00

... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by ... are used to prevent cancer from developing in healthy people. With the approval of the prostate cancer vaccine, Provenge by Dendreon, the field of ...

Oct, 2014 134 pages
Papillary Thyroid Cancer - Pipeline Review, H2 2014 US$ 2,000.00

... Review, H2 2014’, provides an overview of the Papillary Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 75 pages
Metastatic Uveal Melanoma - Pipeline Review, H2 2014 US$ 2,000.00

... Review, H2 2014’, provides an overview of the Metastatic Uveal Melanoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 58 pages
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 US$ 2,000.00

... , H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Oct, 2014 36 pages
Global and Chinese Cervical Plates Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Plates industry covering all important parameters ...

Oct, 2014 150 pages
Global and Chinese Cervical Disc Prostheses Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and ... . Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Disc Prostheses industry covering all important parameters.

Oct, 2014 150 pages
Global and Chinese Cervical Dilators Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Dilators industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Collars Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Collars industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Brushes Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Brushes industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Brush Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Brush industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Cervical Biopsy Forceps Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and ... . Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Cervical Biopsy Forceps industry covering all important parameters.

Oct, 2014 150 pages
Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023”. ... Medicines Agency (EMA) in 2008, for use in locally-advanced or metastatic breast cancer, in combination with Xeloda (capecitabine). In 2010, the FDA and ...

Sep, 2014 55 pages
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... the high treatment rates in the neoadjuvant and adjuvant settings using HER2-targeted therapies in all stages, have helped drive the sales ... afford to reimburse the latest expensive drugs. Scope An overview of HER2-Positive Breast Cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology ...

Sep, 2014 165 pages
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the ... sizing, forecasts and quantified growth opportunities in the Japan HER2-Positive Breast Cancer market through 2018. Quantify candidate patient populations ...

Sep, 2014 158 pages
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the ... sizing, forecasts and quantified growth opportunities in the China HER2-Positive Breast Cancer market through 2018. Quantify candidate patient populations ...

Sep, 2014 154 pages
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 US$ 6,995.00

... , Herceptin is the market leader in France, since it was the first HER2-targeting agent to market. Newly-approved drugs tend to gain market ... approved for use in this setting in the US. Scope An overview of HER2-Positive Breast Cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology ...

Sep, 2014 196 pages
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 ... , unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease ...

Sep, 2014 54 pages
Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... GlobalData has released its new PharmaPoint Drug Evaluation report, “Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023”. ... , unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease ...

Sep, 2014 65 pages
Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... GlobalData has released its new PharmaPoint Drug Evaluation report, “Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 ... 2013, for the second-line treatment of metastatic HER2-positive breast cancer. Kadcyla is an antibody-drug conjugate consisting of trastuzumab covalently linked ...

Sep, 2014 54 pages
Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 US$ 3,495.00

... GlobalData has released its new PharmaPoint Drug Evaluation report, “Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023”. ... , unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease ...

Sep, 2014 58 pages
Global Cancer Kinase Inhibitors Market & Pipeline Insight US$ 2,400.00

... of host effector mechanisms which tend to lead to better therapeutic targets. “Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase ...

Oct, 2014 1500 pages
Global Cancer Monoclonal Antibodies Market & Pipeline Insight US$ 2,400.00

... milestones during this period. The use of mAbs for treating cancer has increased significantly. The rising market availability of these agents has ... of the human cells there is still significant work which needs to be done. “Global Cancer Monoclonal Antibodies Market & Pipeline Insight” Report highlights: ...

Oct, 2014 1400 pages
Global Pancreatic Cancer Market 2014-2018 US$ 2,500.00

... outlines the challenges faced by the vendors. TechNavio's report, the Global Pancreatic Cancer market 2014-2018, has been prepared based on an in-depth ... . The report also includes a discussion of the key vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Celgene Eli ...

Oct, 2014 97 pages
Physician Views: The PD-1 inhibitor class lands – how do US oncologists expect to initially use Merck & Co.'s Keytruda? US$ 645.00

... Yervoy (ipilimumab) and, if BRAF V600-mutation positive, a BRAF inhibitor (see also Physician Views Poll Results – Oncologists suggest Mekinist/Tafinlar combination ... of a multi-billion dollar market over the next decade – this Physician Views poll contains a second component that provides oncologist assessment ...

Sep, 2014
Physician Views: When and where do oncologists see palbociclib fitting into the ER+, HER2- breast cancer landscape? US$ 645.00

... trial showing the drug improved progression-free survival (PFS) by 18.6 months when added to Femara in postmenopausal women with oestrogen receptor (ER) positive, HER2- ... Phase III) and Avastin (accelerated approval based on PFS later revoked when it did not improve OS), would the FDA be right to wait for data ...

Aug, 2014
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation US$ 6,995.00

... and enable marketing executives to strategize their product launches, by allowing them to: Understanding of the focal shifts in molecular targets in the breast cancer pipeline. Understanding of the distribution of pipeline programs by phase of development, molecule type and molecular target. Access a ...

Jul, 2014 116 pages
US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 4,000.00

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

Sep, 2014 136 pages
UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,600.00

This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

Sep, 2014 124 pages
Spain Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,950.00

This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

Sep, 2014 128 pages
Japan Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 3,000.00

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

Sep, 2014 129 pages
Italy Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,500.00

This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in ...

Sep, 2014 125 pages
Germany Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 2,950.00

This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

Sep, 2014 128 pages
France Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 3,200.00

This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

Sep, 2014 100 pages
Europe Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 6,000.00

This unique report from Venture Planning Group provides Europe sales and market share estimates for major suppliers of cancer diagnostic testing ... strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

Sep, 2014 151 pages
Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country US$ 9,200.00

This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of cancer diagnostic testing ... presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products ...

Sep, 2014 174 pages
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 US$ 3,995.00

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 SUMMARY Breast cancer is a malignant tumor that originates in the breast tissues. ... historical data obtained from the WHO International Agency for Cancer Research’s (IARC’s) SurvCan, the Surveillance of Epidemiology and End Results ...

Sep, 2014 70 pages
Global Non-small Cell Lung Cancer Market 2014-2018 US$ 2,500.00

... cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go ... , shortness of breath, and wheezing. TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 3.62 percent over the period ...

Sep, 2014 92 pages
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide US$ 1,490.00

... . This is our 4th report on Cancer Sector. Renub Research study titled “Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide” analyzes the ... through 2018. A six year historic analysis is also provided for these markets. This 258 page report with 252 Figures and 14 Tables ...

Sep, 2014 258 pages
Global Cancer Vaccines Market & Pipeline Analysis US$ 2,400.00

... present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into ... Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for ...

Sep, 2014 864 pages
Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids US$ 3,016.00

... are based on 'real world' market data. Recent years have seen the rapid development of minimally invasive diagnostic techniques in the cancer field, notably so- ... they are providing, into tests that impact on clinical care or which drive new discovery. The current studies profiled more than 855 experienced ...

Sep, 2014 170 pages
The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth US$ 900.00

... growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing ... held a market share of ~% and recorded sales of USD ~ million. The US Anti Cancer Drug Market is expected to grow over the period at a CAGR of 29.4% with ...

Jul, 2014 144 pages
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 US$ 2,000.00

... trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional ... therapy, both conventional and peptide based cancer therapeutics are used for the treatment. “Global Peptide Cancer Therapeutics Market & Pipeline Insight ...

Aug, 2014 556 pages
Global Breast Cancer Market Report: 2014 Edition US$ 800.00

... . The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, ... faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel ...

Aug, 2014 65 pages
PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

... GlobalData's report 'PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022', provides comprehensive information on prostate cancer therapeutics, highlighting ... cancer patients, and how will this change over the forecast period? How will pipeline drugs attempt to meet these needs? ...

Nov, 2012 288 pages
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies US$ 3,900.00

... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...

Aug, 2014 54 pages
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market US$ 4,995.00

... provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation ... most promising pipeline drugs. An epidemiological forecast of the major NSCLC markets, in which projected values include total and treated populations An in-depth ...

Jul, 2014 143 pages
Global Cancer Generics Market Outlook 2018 US$ 1,400.00

... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...

Aug, 2014 100 pages
Cancer Immunotherapy Market & Clinical Pipeline Insight US$ 3,000.00

... depending on the location. With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced ... is one of the major reasons for cancer immunotherapy not being in widespread use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: ...

Jul, 2014 1990 pages
Uterine Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Uterine Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2014 US$ 1,250.00

... Cancer) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed ... . Devise corrective measures for pipeline projects by understanding Transitional Cell Cancer (Urothelial Cell Cancer) pipeline depth and focus of Indication therapeutics ...

Aug, 2014
1 2 3 4 5 >
Skip to top